IWG PLC/ JE00BYVQYS01 /
2024-05-09 11:39:22 AM | Chg. +0.50 | Volume | Bid11:39:29 AM | Ask11:39:22 AM | High | Low |
---|---|---|---|---|---|---|
192.50GBX | +0.26% | 79,238 Turnover(GBP): 152,357.3940 |
192.60Bid Size: 612 | 193.00Ask Size: 615 | 192.80 | 192.00 |
GlobeNewswire
03-26
argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thr...
GlobeNewswire
2023-12-11
Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of H...
GlobeNewswire
2023-11-28
argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocyt...
Newsfile Corp
2023-10-05
GoGlobal Announces Partnership with IWG to Offer Office Space and Hybrid Working Solutions to Client...
GlobeNewswire
2021-12-13
Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050...
GlobeNewswire
2021-12-13
Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program an...
GlobeNewswire
2021-11-12
Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML
GlobeNewswire
2021-08-09
HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazeme...
GlobeNewswire
2021-02-25
Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance
GlobeNewswire
2020-12-28
Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 ...
GlobeNewswire
2020-12-06
MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 202...
GlobeNewswire
2020-06-12
Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt)...
GlobeNewswire
2020-04-27
MacroGenics Announces Presentation of Flotetuzumab Translational Data at the 2020 AACR Annual Meetin...
GlobeNewswire
2020-02-20
Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
GlobeNewswire
2019-12-12
Recap and Update of Positive Data from Phase Ib/II Clinical Trials of APR-246 and Azacitidine (AZA) ...
GlobeNewswire
2019-12-10
Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (or...